Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Sunshine Biopharma (SBFM)
NASDAQ:SBFM
RESEARCH TOOLSreports
Holding SBFM?
Track your performance easily
SBFM Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$2.42 - $781.61
Previous Close$2.82
Volume44.32K
Average Volume (3M)101.53K
Market Cap
$3.45M
Enterprise Value-$8.06M
Total Cash (Recent Filing)$11.51M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)―
Beta0.83
Next Earnings
Nov 04, 2024EPS Estimate
-$535Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-205.36
Shares Outstanding1,224,341
10 Day Avg. Volume50,978
30 Day Avg. Volume101,529
Standard Deviation4.22
R-Squared0.01
Alpha0.87
Financial Highlights & Ratios
Price to Book (P/B)0.15
Price to Sales (P/S)0.11
Price to Cash Flow (P/CF)N/A
P/FCF Ratio3498.10
Enterprise Value/Market CapN/A
Enterprise Value/Revenue-0.26
Enterprise Value/Gross Profit-0.97
Enterprise Value/Ebitda2.30
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Sunshine Biopharma News
PremiumCompany Announcements
Sunshine Biopharma’s Revenues and Profits Surge
PremiumCompany Announcements
Sunshine Biopharma’s Revenue Soars 54% in Q1
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
SBFM FAQ
What was Sunshine Biopharma’s price range in the past 12 months?
Sunshine Biopharma lowest stock price was $2.42 and its highest was $781.61 in the past 12 months.
What is Sunshine Biopharma’s market cap?
Currently, no data Available
When is Sunshine Biopharma’s upcoming earnings report date?
Sunshine Biopharma’s upcoming earnings report date is Nov 04, 2024 which is in 45 days.
How were Sunshine Biopharma’s earnings last quarter?
Sunshine Biopharma released its earnings results on Aug 19, 2024. The company reported -$9.94 earnings per share for the quarter, missing the consensus estimate of -$0.6 by -$9.34.
Is Sunshine Biopharma overvalued?
According to Wall Street analysts Sunshine Biopharma’s price is currently Overvalued.
Does Sunshine Biopharma pay dividends?
Sunshine Biopharma does not currently pay dividends.
What is Sunshine Biopharma’s EPS estimate?
Sunshine Biopharma’s EPS estimate is -$535.
How many shares outstanding does Sunshine Biopharma have?
Sunshine Biopharma has 1,224,341 shares outstanding.
What happened to Sunshine Biopharma’s price movement after its last earnings report?
Sunshine Biopharma reported an EPS of -$9.94 in its last earnings report, missing expectations of -$0.6. Following the earnings report the stock price went up 5.822%.
Which hedge fund is a major shareholder of Sunshine Biopharma?
Currently, no hedge funds are holding shares in SBFM
---
Sunshine Biopharma Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Neutral
SBFM Sentiment 50%
Sector Average 71%
Sector Average 71%
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.5%
Last 30 Days ▼ 4.8%
Last 30 Days ▼ 4.8%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-99.64%
12-Months-Change
Fundamentals
Return on Equity
-15.79%
Trailing 12-Months
Asset Growth
3.14%
Trailing 12-Months
Company Description
Sunshine Biopharma
Sunshine Biopharma, Inc. engages in the the research, development and commercialization of drugs for the treatment of various forms of cancer. Its products include Adva-27a, SBI-Anastrozol, SBI-Letrozole, SBI-Bicalutamide, SBI-Finasteride, and Essential 9. The company was founded on August 31, 2006 and is headquartered in Montreal, Canada.
---
SBFM Stock 12 Month Forecast
Average Price Target
―Technical Analysis
---